The Burden of Mental and Substance Use Disorders: Findings from the Global Burden of Disease Study 2015 and How to Access These Findings for Your Research

Date/Time
Date(s) - Tuesday, October 25th, 2016
8:30 am - 9:30 am


T32 Seminar
Speaker: Drs. Holly Erskine and Harvey Whiteford 

Dr. Holly Erskine is a research fellow with the Psychiatric Epidemiology and Burden of Disease Group at the Queensland Centre for Mental Health Research in Queensland, Australia. She also holds affiliate positions with the School of Public Health and the Centre for Clinical Research at the University of Queensland, Queensland, Australia, and the Institute for Health Metrics and Evaluation at the University of Washington. Holly’s focus is the epidemiology, burden, and outcomes associated with mental disorders of childhood with a particular focus on conduct disorder and ADHD, which were the subject of her PhD. In the Global Burden of Disease Studies, Holly is responsible for the systematic review, data extraction, and epidemiological modelling of conduct disorder, ADHD, autism, Asperger’s syndrome, anorexia nervosa, bulimia nervosa, and fetal alcohol syndrome as well as cause of death modelling for eating disorders, anorexia nervosa, and bulimia nervosa. She has served as a reviewer for a number of journals, provided expertise to the Australian Young Minds Matter survey, and presented at several domestic and international conferences including the most recent IFPE conference in Bergen, Norway.

Dr. Harvey Whiteford trained in medicine, psychiatry and health policy at the University of Queensland, Stanford University and the Australian National University. He has held senior clinical and administrative positions, including those of Director of Mental Health in the Queensland and Federal governments in Australia. He worked for ten years on the design and implementation of Australia’s Mental Health Strategy and was Chairman of the Working Group which oversaw this initiative. In 1999 he was appointed to the first mental health position in the World Bank in Washington DC with the task of developing the Bank’s capacity to respond to the rising global burden of mental, neurological and substance use disorders. Professor Whiteford leads the Policy and Epidemiology Group at the Queensland Centre for Mental Health Research, which has a research program in psychiatric epidemiology, burden of disease, mental health policy analysis and the reform of mental health services. He has worked as a consultant to national governments, Commonwealth and State governments in Australia, the World Bank and the World Health Organisation. He has clinical responsibilities in general adult psychiatry, teaches undergraduate and postgraduate students.